Online citations, reference lists, and bibliographies.
← Back to Search

Nitric Oxide And Atherosclerosis: An Update.

C. Napoli, F. de Nigris, S. Williams-Ignarro, O. Pignalosa, V. Sica, L. Ignarro
Published 2006 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Nitric oxide (NO) is a molecule that has gained recognition as a crucial modulator of vascular disease. NO has a number of intracellular effects that lead to vasorelaxation, endothelial regeneration, inhibition of leukocyte chemotaxis, and platelet adhesion. Endothelium damage induced by atherosclerosis leads to the reduction in bioactivity of endothelial NO synthase (eNOS) with subsequent impaired release of NO together with a local enhanced degradation of NO by increased generation of reactive oxygen species with subsequent cascade of oxidation-sensitive mechanisms in the arterial wall. Many commonly used vasculoprotective agents have their therapeutic actions through the production of NO. L-Arginine, the precursor of NO, has demonstrated beneficial effects in atherosclerosis and disturbed shear stress. Finally, eNOS gene polymorphism might be an additional risk factor that may contribute to predict cardiovascular events. However, further studies are needed to understand the possible clinical implications of these correlations.
This paper references
10.1161/01.ATV.0000061735.85377.40
Increased Superoxide Production in Coronary Arteries in Hyperhomocysteinemia: Role of Tumor Necrosis Factor-&agr;, NAD(P)H Oxidase, and Inducible Nitric Oxide Synthase
Z. Ungvari (2003)
10.1073/PNAS.0409058101
Erratum: Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101, 23 (8797-8802))
C. Napoli (2004)
10.1152/AJPHEART.2000.278.5.H1679
Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice.
K. Kauser (2000)
10.1016/S0735-1097(02)02306-9
Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells.
C. Napoli (2002)
10.1161/HQ0202.104124
Gene Transfer of Endothelial NO Synthase and Manganese Superoxide Dismutase on Arterial Vascular Cell Adhesion Molecule-1 Expression and Superoxide Production in Deoxycorticosterone Acetate-Salt Hypertension
L. Li (2002)
10.1016/J.IJCARD.2005.02.039
Genetic polymorphisms G894T on the eNOS gene is associated with endothelial function and vWF levels in premature myocardial infarction survivors.
C. Antoniades (2006)
10.1136/heart.86.3.296
Vasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaque
D. Tousoulis (2001)
10.1016/S0014-2999(02)02046-0
Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats.
V. De Gennaro Colonna (2002)
10.1515/9783111576855-016
K
Martin P. Catherwood (1824)
10.1016/S0008-6363(99)00162-5
Biological significance of endogenous methylarginines that inhibit nitric oxide synthases.
J. Leiper (1999)
10.1161/01.CIR.99.9.1236
Regression of atherosclerosis: role of nitric oxide and apoptosis.
B. Wang (1999)
EVect of hypercholesterolemia on vascular reactivity in the rabbit
T. J. Verbeuren (1986)
10.1161/01.CIR.0000125742.65841.8B
Antioxidant Intervention Attenuates Myocardial Neovascularization in Hypercholesterolemia
X. Zhu (2004)
10.1016/J.AHJ.2004.05.059
A polymorphism of the endothelial nitric oxide synthase promoter is associated with an increase in autonomic imbalance in patients with congestive heart failure.
P. Binkley (2005)
10.1161/01.ATV.0000118682.58708.78
Peroxisome Proliferator-Activated Receptor &agr; Agonists Increase Nitric Oxide Synthase Expression in Vascular Endothelial Cells
K. Goya (2004)
10.1161/01.CIR.101.18.2206
Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries.
C. Berry (2000)
10.1253/CIRCJ.66.811
Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus.
A. Ito (2002)
Low density lipoprotein oxidation and its pathobiological signiWcance
D. Steinberg (1997)
10.1161/01.ATV.0000046230.02211.B4
Short-Term Triglyceride Lowering With Fenofibrate Improves Vasodilator Function in Subjects With Hypertriglyceridemia
W. Capell (2003)
10.5040/9781474284028.0024
S
A. Kumar (1824)
10.1002/jcb.1094
Cyclic strain induces reactive oxygen species production via an endothelial NAD(P)H oxidase
H. Matsushita (2001)
Oxidation of LDL
C. Napoli (2003)
Atherosclerosis—an inXammatory disease
R. Ross (1999)
Cell and molecular biology of nitric oxide syntheses
O. Feron (2000)
10.1515/CCLM.2004.257
Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay
F. Schulze (2004)
10.1073/PNAS.0401996101
Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties.
E. Ongini (2004)
10.1016/S1089-8603(03)00028-4
Enhanced vasoconstrictor responses in eNOS deficient mice.
K. Lamping (2003)
10.1515/9783111697888-004
B
B. A. R. Kernfach (1824)
10.1016/J.AHJ.2004.05.019
Endothelial nitric oxide synthase gene polymorphism and ischemic heart disease.
M. Spence (2004)
10.1161/01.CIR.85.5.1927
Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity.
N. Flavahan (1992)
10.1161/01.ATV.19.3.646
Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages.
C. Baker (1999)
10.1016/J.AMJCARD.2003.10.022
Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome.
Tzung-Dau Wang (2004)
Sulfhydryl ACE inhibition induces a sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension
C. Napoli (2004)
10.1073/pnas.0237367100
Beneficial effects of antioxidants and l-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress
F. de Nigris (2003)
10.1016/S0002-9149(99)00129-0
Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris.
A. Blum (1999)
10.1016/S0021-9150(99)00366-4
Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study.
F. G. Fowkes (2000)
10.1016/S1567-5769(01)00094-7
The physiological role and pharmacological potential of nitric oxide in neutrophil activation.
R. Armstrong (2001)
10.1161/01.CIR.101.18.2160
Oral L-arginine in patients with coronary artery disease on medical management.
A. Blum (2000)
10.1161/01.CIR.99.15.2003
Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries.
C. Napoli (1999)
Stemerman, Native low-density lipoprotein increases endothelial cell NO synthase generation of superoxide anion
K. A. Pritchard (1995)
10.1097/00005344-199912000-00016
Nitric oxide as a signaling molecule in the vascular system: an overview.
L. Ignarro (1999)
10.1074/JBC.274.28.19814
Stimulation of a Vascular Smooth Muscle Cell NAD(P)H Oxidase by Thrombin
C. Patterson (1999)
10.1161/01.HYP.30.1.57
Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients.
C. Cardillo (1997)
10.1152/AJPHEART.2001.281.3.H981
Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?
Z. Katušić (2001)
Peroxisome proliferator - activated receptor  agonists increase nitric oxide synthase expression in vascular endothelial cells , Arterioscler
H. Yamamoto (2004)
10.1084/jem.20031132
KLF2 Is a Novel Transcriptional Regulator of Endothelial Proinflammatory Activation
S. Senbanerjee (2004)
10.1016/S0002-9149(02)02847-3
Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus.
D. Playford (2002)
10.1016/S0140-6736(05)61692-3
Coronary stenosis dilatation induced by L-arginine
D. Tousoulis (1997)
10.1161/CIRCULATIONAHA.104.525774
Kruppel-Like Factor 2 as a Novel Mediator of Statin Effects in Endothelial Cells
S. Senbanerjee (2005)
10.1096/fj.00-0141com
Anti‐monocyte chemoattractant protein‐1 gene therapy inhibits vascular remodeling in rats: blockade of MCP‐1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis
K. Egashira (2000)
10.1002/jcp.20298
Nitric oxide stimulated vascular smooth muscle cells undergo apoptosis induced in part by arachidonic acid derived eicosanoids
C. Pilane (2005)
10.1161/01.CIR.0000126823.07732.D5
Asymmetrical Dimethylarginine: The Über Marker?
J. Cooke (2004)
10.1161/01.CIR.101.15.1773
Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus.
M. Evans (2000)
10.1161/01.RES.0000159707.05637.a1
Kruppel-Like Factor 2 (KLF2) Regulates Endothelial Thrombotic Function
Z. Lin (2005)
10.1002/jcb.1198
Multiple role of reactive oxygen species in the arterial wall
C. Napoli (2001)
10.1161/01.HYP.27.3.823
Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle.
K. Fukuo (1996)
10.1146/ANNUREV.PHARMTOX.43.100901.140226
Nitric oxide-releasing drugs.
C. Napoli (2003)
10.1016/0014-5793(95)00307-U
Peroxynitrite‐mediated oxidative protein modifications
H. Ischiropoulos (1995)
10.1016/S0140-6736(94)92346-9
The oxidation hypothesis of atherosclerosis
J. Witztum (1994)
10.1096/fj.02-0226rev
The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol‐lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis
W. Palinski (2002)
10.1161/HC4501.099729
Hypertension Does Not Account for the Accelerated Atherosclerosis and Development of Aneurysms in Male Apolipoprotein E/Endothelial Nitric Oxide Synthase Double Knockout Mice
J. Chen (2001)
10.1016/S0735-1097(97)00046-6
Basal and flow-mediated nitric oxide production by atheromatous coronary arteries.
D. Tousoulis (1997)
10.1177/107424840400900i101
Nitric Oxide and Other Novel Therapies for Pulmonary Hypertension
C. Napoli (2004)
10.1016/0002-9149(93)90252-8
Role of endothelium in ischemic coronary syndromes.
I. Meredith (1993)
10.1046/J.1525-1373.1999.D01-136.X
On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction.
B. Frei (1999)
10.1016/J.CARDIORES.2003.09.027
Gene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits.
T. Hayashi (2004)
BeneWcial eVects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial nitric oxide synthase activity at sites of disturbed shear stress
F. De Nigris (2003)
10.1161/01.RES.87.10.840
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress.
H. Cai (2000)
10.1515/9783111576855-012
G
G.V.T.V. Weerasooriya (1824)
10.1161/01.CIR.101.16.1982
Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation.
F. Tanner (2000)
E V ect of feno W brate on brachial artery X owmediated dilatation in type 2 diabetes melli
G. F. Watts (2002)
10.1007/S11883-001-0068-X
Atherogenesis and the arginine hypothesis
J. Cooke (2001)
10.1016/S0008-6363(99)00152-2
Nitric oxide and coronary endothelial dysfunction in humans.
H. Drexler (1999)
10.1097/01.ASN.0000117774.83396.E9
Antioxidant intervention blunts renal injury in experimental renovascular disease.
A. Chade (2004)
10.1016/S0140-6736(05)61503-6
T
D. Davies (1998)
10.1073/pnas.192244499
Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice
C. Napoli (2002)
10.1016/0735-1097(92)90513-M
Effect of acetylcholine on the highly stenotic coronary artery: difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related artery.
K. Okumura (1992)
10.1007/s004280050384
Expression of inducible nitric oxide synthase in macrophages and smooth muscle cells in various types of human atherosclerotic lesions
J. Luoma (1999)
10.1172/JCI119813
Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.
C. Napoli (1997)
10.1016/J.EJVS.2004.02.008
Influence of eNOS gene polymorphisms on carotid atherosclerosis.
C. Fatini (2004)
Nitric oxide: physiology, pathophysiology, and pharmacology.
S. Moncada (1991)
10.1016/S1471-4914(03)00139-4
Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis.
F. de Nigris (2003)
10.1161/01.CIR.101.11.1261
Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production : key role of L-arginine availability.
L. Vergnani (2000)
10.1161/01.ATV.17.4.737
Induction of nitric oxide synthase in the neointima induced by a periarterial collar in rabbits.
J. Arthur (1997)
10.2174/0929867054367257
New trends in anti-atherosclerotic agents.
C. Napoli (2005)
10.1172/JCI114477
Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.
C. Boulanger (1990)
Ignarro, Regulation of inducible nitric oxide synthase expression in advanced glycation end product-stimulated raw 264.7 cells: the role of heme oxygenase-1 and endogenous nitric oxide, Diabetes
L.J.D. Sumi (2004)
10.1196/annals.1299.127
Oxidation of LDL, Atherogenesis, and Apoptosis
C. Napoli (2003)
Shears II , Endothelial NO synthase protects aortic allografts from the development of transplant arteriosclerosis
Z. L. Wang (2000)
10.1161/01.RES.85.5.394
Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway.
Philippe Delerive (1999)
10.1373/49.3.389
Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease.
M. Colombo (2003)
10.1016/J.AHJ.2004.03.025
Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
C. Napoli (2004)
10.1136/heart.89.6.597
Microarray analysis: a novel research tool for cardiovascular scientists and physicians
C. Napoli (2003)
10.1016/S0735-1097(98)00167-3
Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction.
Y. Shimasaki (1998)
10.1161/01.ATV.0000069209.26507.BF
Hypercholesterolemia and Hypertension Have Synergistic Deleterious Effects on Coronary Endothelial Function
M. Rodriguez-Porcel (2003)
10.1161/01.STR.32.3.735
A Common Variant of Endothelial Nitric Oxide Synthase (Glu298Asp) Is an Independent Risk Factor for Carotid Atherosclerosis
G. Lembo (2001)
Accelerated atherosclerosis.
S. S. Samra (2002)
10.1161/01.CIR.97.1.108
Atherosclerosis and the two faces of endothelial nitric oxide synthase.
R. Wever (1998)
10.1007/s00109-005-0641-9
Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) in patients with coexistent hypertrophic cardiomyopathy and coronary spastic angina
A. Ogimoto (2005)
10.2337/DIACARE.27.3.765
Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
L. Tarnow (2004)
10.1161/01.ATV.0000128897.54893.26
Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway
P. Vallance (2004)
10.1006/NIOX.2001.0337
Nitric oxide and atherosclerosis.
C. Napoli (2001)
10.1023/A:1020537506008
Endothelium-Derived Relaxing Factor: Discovery, Early Studies, and Identification as Nitric Oxide
R. Furchgott (1999)
10.1016/S0140-6736(99)02131-5
Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study
C. Napoli (1999)
10.1056/NEJM199901143400207
Atherosclerosis is an inflammatory disease.
R. Ross (1999)
10.1161/HH0102.102330
Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview.
L. Ignarro (2002)
10.1161/01.CIR.0000015853.59427.32
Paradoxical Reduction of Fatty Streak Formation in Mice Lacking Endothelial Nitric Oxide Synthase
Weibin Shi (2002)
Nitric oxide regulates exocytosis by Snitrosylation of Nethylmaleimidesensitive factor
C. N. Morrell (2003)
Nitric oxide ( NO )releasing statin derivatives , a class of drugs showing enhanced antiproliferative and antiin X ammatory properties
F. Impagnatiello E. Ongini (2004)
10.1126/SCIENCE.1117728
Calorie Restriction Promotes Mitochondrial Biogenesis by Inducing the Expression of eNOS
E. Nisoli (2005)
10.1007/S11892-005-0062-8
Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis
L. Ignarro (2004)
10.1161/01.STR.0000126482.86708.37
Endothelial Function and Carotid Intima-Media Thickness in Young Healthy Subjects Among Endothelial Nitric Oxide Synthase Glu298→Asp and T−786→C Polymorphisms
U. Paradossi (2004)
10.1161/01.CIR.98.18.1842
Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
R. Böger (1998)
10.1515/9783111548050-034
W
Lohmarer Stadtgeschichte (2005)
10.1161/01.CIR.0000121357.76910.A3
Endothelial Nitric Oxide Synthase Genotype and Ischemic Heart Disease: Meta-Analysis of 26 Studies Involving 23028 Subjects
J. Casas (2004)
10.1161/01.RES.59.5.496
Effect of Hypercholesterolemia on Vascular Reactivity in the Rabbit. II. Influence of Treatment With Dipyridamole on Endothelium-Dependent and Endothelium‐Independent Responses in Isolated Aortas of Control and Hypercholesterolemic Rabbits
T. J. Verbeuren (1986)
10.1161/01.ATV.20.9.2032
Does ADMA cause endothelial dysfunction?
J. Cooke (2000)
10.1016/J.JVS.2005.05.044
eNOS G894T polymorphism as a mild predisposing factor for abdominal aortic aneurysm.
C. Fatini (2005)
10.1073/PNAS.0408310102
Regulation of platelet granule exocytosis by S-nitrosylation.
C. Morrell (2005)
Expression of interleukin10 in advanced human atherosclerotic plaques : relation to inducible nitric oxide synthase expression and cell death , Arterioscler
Z. Mallat (1999)
10.1016/0140-6736(91)92372-9
Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine
H. Drexler (1991)
10.1161/01.RES.77.3.510
Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion.
K. Pritchard (1995)
10.4065/76.6.619
Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia.
C. Napoli (2001)
10.1073/PNAS.87.4.1620
Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.
J. Beckman (1990)
10.3109/07853899509002593
Endogenous nitric oxide in cardiovascular disease and transplantation.
G. Dusting (1995)
Role of endogenous NO in progression of atherosclerosis in apolipoprotein E-deWcient mice
K. Kauser (2000)
Regulation of inducible nitric oxide synthase
G. Feng (1997)
10.1042/BST025383SC
NITRIC OXIDE PHYSIOLOGY
S. Moncada (1997)
10.1016/S0092-8674(03)00803-1
Nitric Oxide Regulates Exocytosis by S-Nitrosylation of N-ethylmaleimide-Sensitive Factor
K. Matsushita (2003)
10.1093/CLINCHEM/48.7.989
Independent risk factor for moderate to severe internal carotid artery stenosis: T786C mutation of the endothelial nitric oxide synthase gene.
G. Ghilardi (2002)
10.1097/01.mca.0000073080.69657.71
The Glu298Asp polymorphism in the endothelial nitric oxide synthase gene is strongly associated with coronary spasm
K. Chang (2003)
Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability.
S. Björkerud (1996)
10.1016/S0021-9150(98)00180-4
Ex vivo gene transfer of endothelial nitric oxide synthase to atherosclerotic rabbit aortic rings improves relaxations to acetylcholine.
G. Mozes (1998)
10.1172/JCI115987
L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.
M. Creager (1992)
Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase
VinodAchan (2003)
10.1161/HC2901.091399
Accelerated Atherosclerosis, Aortic Aneurysm Formation, and Ischemic Heart Disease in Apolipoprotein E/Endothelial Nitric Oxide Synthase Double-Knockout Mice
P. Kuhlencordt (2001)
10.1161/01.CIR.100.14.1515
A common variant of the endothelial nitric oxide synthase (Glu298-->Asp) is a major risk factor for coronary artery disease in the UK.
A. Hingorani (1999)
10.1161/01.CIR.99.23.2979
Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits.
H. Qian (1999)
10.1161/01.CIR.90.1.5
Vasoreactivity of the Culprit Lesion in Unstable Angina
P. Bogaty (1994)
10.2174/1381612043453388
Statin treatment and the natural history of atherosclerotic-related diseases: pathogenic mechanisms and the risk-benefit profile.
C. Napoli (2004)
10.1161/01.ATV.0000015598.86369.04
Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors in Lipid Metabolism and Atherosclerosis
O. Barbier (2002)
10.1016/S0002-9149(02)03144-2
Role of oxidative stress in atherosclerosis.
D. Harrison (2003)
10.1042/CS20030360
An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in men.
W. R. Agema (2004)
10.1056/NEJM199908053410604
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.
H. Rubins (1999)
10.1074/jbc.272.34.20963
Low Density Lipoprotein Oxidation and Its Pathobiological Significance*
D. Steinberg (1997)
10.1016/S0002-9149(98)00563-3
Effects of changing the availability of the substrate for nitric oxide synthase by L-arginine administration on coronary vasomotor tone in angina patients with angiographically narrowed and in patients with normal coronary arteries.
D. Tousoulis (1998)
10.1161/01.STR.28.11.2266
Mildly oxidized low-density lipoprotein impairs responses of carotid but not basilar artery in rabbits.
C. Napoli (1997)
10.1074/jbc.M309451200
Nitric Oxide Production and Regulation of Endothelial Nitric-oxide Synthase Phosphorylation by Prolonged Treatment with Troglitazone
Du-Hyong Cho (2004)
10.1172/JCI115549
Inactivation of endothelial derived relaxing factor by oxidized lipoproteins.
J. Chin (1992)
10.1007/s11883-004-0059-9
Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis
L. Ignarro (2005)
E V ects of rosiglitazone on endothelial function , c - reactive protein , and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome
T. J. Rabelink (2004)
10.1161/01.CIR.0000028581.07992.56
Endothelial function: a barometer for cardiovascular risk?
J. Vita (2002)
10.1097/00008571-200003000-00005
High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery disease.
K. Stangl (2000)
10.1097/00007890-200003270-00025
Endothelial nitric oxide synthase protects aortic allografts from the development of transplant arteriosclerosis.
P. Lee (2000)
10.1161/01.HYP.32.3.521
Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction.
K. Hibi (1998)
10.1002/path.915
Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E‐deficient and LDL receptor‐deficient mice
F. Calara (2001)
Jukema, An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease
W. R. Agema (2004)
10.1016/S1071-3581(00)90028-X
Effect of l-arginine administration on myocardial thallium-201 perfusion during exercise in patients with angina pectoris and normal coronary angiograms
H. Fujita (2000)
10.1177/000331970405500101
L-Arginine Ameliorates the Abnormal Sympathetic Response of the Dysfunctional Human Coronary Microvasculature
J. Gellman (2004)
10.1016/S0021-9150(98)00254-8
Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits.
D. Behr (1999)
NAD ( P ) H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropa
R. H. Boger (2005)
10.1016/J.BBRC.2003.10.036
A calcium channel blocker activates both ecto-5(')-nucleotidase and NO synthase in HUVEC.
Y. Asano (2003)
10.1002/(SICI)1096-9896(200002)190:3<267::AID-PATH523>3.0.CO;2-A
The role of apoptosis in vascular disease
M. Kockx (2000)
10.1161/01.CIR.97.12.1129
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
U. Laufs (1998)
10.1161/01.RES.82.11.1111
Apoptosis: basic mechanisms and implications for cardiovascular disease.
A. Haunstetter (1998)
10.1038/nrm762
Does nitric oxide modulate mitochondrial energy generation and apoptosis?
S. Moncada (2002)
10.1152/AJPRENAL.00221.2004
NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.
M. Satoh (2005)
10.1161/01.CIR.97.21.2123
Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans.
A. Lerman (1998)
10.1016/S0021-9150(96)05976-X
Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits.
T. Esaki (1997)
10.1016/J.ATHEROSCLEROSIS.2004.01.025
L-arginine attenuates lymphocyte activation and anti-oxidized LDL antibody levels in patients undergoing angioplasty.
J. George (2004)
10.1161/01.ATV.19.3.611
Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death.
Z. Mallat (1999)
10.1002/AJMG.1229
Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis.
T. Guzik (2001)
10.1161/HS1101.098520
Age-Related Effects on Atherogenesis and Scavenger Enzymes of Intracranial and Extracranial Arteries in Men Without Classic Risk Factors for Atherosclerosis
F. D'armiento (2001)
Increased superoxide production in coronary arteries in hyperhomocysteinemia : role of tumor necrosis factor - alpha , NAD ( P ) H oxidase , and inducible nitric oxide synthase , Arterioscler
J. Leiper P. Vallance (2003)
10.1016/S0140-6736(00)04209-4
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study
Diabetes Atherosclerosis Intervention Study Investigators (2001)
10.1097/01.crd.0000137255.54390.12
Peroxisome Proliferator-Activated Receptor-Alpha and Atherosclerosis: From Basic Mechanisms to Clinical Implications
Zarmen Israelian-Konaraki (2005)
Regression of atherosclerosis: role of NO and apoptosis
B. Y. Wang (1999)



This paper is referenced by
The cardiovascular effects of Clausena Anisata Extracts in Experimental Hypertension
N. M. Lechaba (2011)
10.1615/CRITREVBIOMEDENG.V39.I5.40
Nitric oxide signaling in the microcirculation.
D. Buerk (2011)
10.1016/J.CARDIORES.2006.08.021
Effects of a pomegranate fruit extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis.
F. de Nigris (2007)
10.1007/s11883-010-0156-x
Developmental Mechanisms Involved in the Primary Prevention of Atherosclerosis and Cardiovascular Disease
C. Napoli (2011)
10.1016/j.niox.2009.04.003
Whole-body basal nitric oxide production is impaired in postprandial endothelial dysfunction in healthy rats.
Joëlle Magné (2009)
10.1016/B978-0-12-384937-3.00070-7
The Role of Individual Tea Compounds in Cardiovascular Protective Effects of Green and Black Tea
M. Lorenz (2013)
10.3390/nu12020575
Vitamin D and Endothelial Function
Do-Houn Kim (2020)
10.2174/1381612825666191112091700
Aging Methotrexate and Vasculoprotection: Mechanistic Insights and Potential Therapeutic Applications in Old Age.
A. Mangoni (2019)
10.1007/s00380-014-0557-9
Possible role of fibroblast growth factor 21 on atherosclerosis via amelioration of endoplasmic reticulum stress-mediated apoptosis in apoE−/− mice
Xi Wu (2014)
10.1016/J.BJBAS.2016.02.004
Therapeutic agents for the management of atherosclerosis from herbal sources
A. Kajal (2016)
Investigation of eNOS gene intron 4 A/B VNTR and intron 23 polymorphisms in patients with essential hypertension.
Idris Mehmetoglu (2010)
10.1111/j.1600-0609.2007.01007.x
Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease
A. Liguori (2008)
Protective effects of luteolin on vascular endothelial injury in rats with atherosclerosis
Z. Su (2019)
10.1142/S0192415X08005977
Anti-atherogenic effects of the aqueous extract of rhubarb in rats fed an atherogenic diet.
Mi Kyoung Moon (2008)
10.2147/VHRM.S2177
Relaxin as a natural agent for vascular health
D. Bani (2008)
10.2337/db09-0167
Foxo1 Links Hyperglycemia to LDL Oxidation and Endothelial Nitric Oxide Synthase Dysfunction in Vascular Endothelial Cells
Jun Tanaka (2009)
10.1007/s00380-007-1015-8
Beneficial effects of low doses of red wine consumption on perturbed shear stress-induced atherogenesis
C. Napoli (2007)
10.5142/jgr.2013.37.54
Ginsenoside Rd inhibits the expressions of iNOS and COX-2 by suppressing NF-κB in LPS-stimulated RAW264.7 cells and mouse liver
D. Kim (2013)
10.1016/j.taap.2010.07.025
Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway.
Hsiu-Chung Ou (2010)
10.18585/inabj.v12i3.1241
Correlations between Total Antioxidant Capacity and 8-Hydroxydeoxyguanosine with Carotid-Femoral Pulse Wave Velocity in Chronic Kidney Disease
Mochammad Yusuf Alsagaff (2020)
10.1128/AEM.02303-19
Nitric Oxide Improves the Tolerance of Pleurotus ostreatus to Heat Stress by Inhibiting Mitochondrial Aconitase
L. Hou (2019)
10.1007/s13204-018-0856-z
The use of nanotechnology in cardiovascular disease
Meera Chandarana (2018)
10.1117/12.2038329
Combination of nitric oxide therapy, anti-oxidative therapy, low level laser therapy, plasma rich platelet therapy and stem cell therapy as a novel therapeutic application to manage the pain and treat many clinical conditions
Salaheldin Halasa (2014)
10.1080/10715760701732830
Microcirculation and oxidative stress
E. Crimi (2007)
10.1002/rcm.3841
A novel derivative for the assessment of urinary and salivary nitrate using gas chromatography/mass spectrometry.
S. Jackson (2008)
10.1007/s00772-008-0668-7
Therapeutisches Potenzial der Stickstoffmonoxid-Synthase-Isoformen in Restenose, Transplantat- und Bypassarteriosklerose
P. Padmapriya (2008)
10.1161/CIRCIMAGING.113.000785
Chronic Dipeptidyl Peptidase-4 Inhibition With Sitagliptin Is Associated With Sustained Protection Against Ischemic Left Ventricular Dysfunction in a Pilot Study of Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
L. Mccormick (2014)
10.1016/j.vph.2019.05.001
Nitric oxide donor molsidomine favors features of atherosclerotic plaque stability and reduces myocardial infarction in mice.
L. Roth (2019)
Growth of lettuce with different content of inorganic nitrate as a feeding strategy for placebo-controlled nutritional interventions to test the effects of inorganic nitrate on human health
O. Qadir (2017)
10.1161/ATVBAHA.118.311572
Amino Acids and Their Metabolism in Atherosclerosis
Katrin Nitz (2019)
10.1586/17512433.2013.841077
Effects of red wine on established markers of arterial structure and function in human studies: current knowledge and future research directions
A. Mangoni (2013)
10.2217/fca-2016-0012
Novel biomarkers of coronary microvascular disease.
O. Hung (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar